ArticleMolecular therapy. Methods & clinical development2022
Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine.
Christine E EngelandPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it